🟢 MaxLinear is trading 10% up in pre-market on Q3 beat and above-consensus Q4 guidance

MaxLinear is trading 10.08% up in pre-market at $71.86 after Q3 beat estimates and Q4 guidance topped consensus.

• Q3 revenue was $218.1 million; non-GAAP diluted EPS was $0.62, both above estimates. Q4 revenue guidance was $240 million–$260 million, above consensus.
• Shares closed at $65.28 on October 22, following a 13.87% session decline; a report noted an initial after-hours drop.
• Semiconductor-sector weakness is a countervailing backdrop, not an apparent explanation for the pre-market rise.